If you’ve heard about Medicare’s new GLP-1 Bridge Program, you may be wondering: “Will Medicare pay for Wegovy® in 2026?” The short answer is yes—but it depends on why you’re taking Wegovy and whether you meet the program’s...
The Health Benefits of GLP-1 Medications: More Than Weight Loss GLP-1 medications have transformed the treatment of obesity and Type 2 diabetes. While many people first hear about these medications because of their impressive weight-loss results, research has shown...
Over the past several years, GLP-1 medications have transformed the treatment of obesity and Type 2 diabetes. While many people recognize these medications for their ability to promote significant weight loss, researchers have discovered that their benefits extend far...
A Review of the Science Behind Medicare’s New Approach to Obesity Treatment and Cardiovascular Disease Prevention Beginning in July 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program, a temporary demonstration...
For many people, losing weight isn’t simply a matter of eating less and exercising more. Obesity is now recognized as a chronic medical condition influenced by genetics, hormones, metabolism, medications, stress, sleep, and lifestyle. Fortunately, advances in...
